EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Hepatic encephalopathy: current challenges and future prospects

Mirashini Swaminathan, Mark Alexander Ellul, Timothy Js Cross

Hepatic Medicine: Evidence and Research · 2018

DOI: 10.2147/hmer.s118964 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Hepatic Medicine: Evidence and Research, 2018. Verfasst von Mirashini Swaminathan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Royal Liverpool University Hospital. Die Arbeit wurde bisher 38-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatic encephalopathy (HE) is a common complication of liver dysfunction, including acute liver failure and liver cirrhosis. HE presents as a spectrum of neuropsychiatric symptoms ranging from subtle fluctuating cognitive impairment to coma. It is a significant contributor of morbidity in patients with liver disease. HE is observed in acute liver failure, liver bypass procedures, for example, shunt surgry and transjugular intrahepatic portosystemic shunt, and cirrhosis. These are classified as Type A, B and C HE, respectively. HE can also be classified according to whether its presence is overt or covert. The pathogenesis is linked with ammonia and glutamine production, and treatment is based on mechanisms to reduce the formation and/or removal of these compounds. There is no specific diagnostic test for HE, and diagnosis is based on clinical suspicion, excluding other causes and use of clinical tests that may support its diagnosis. Many tests are used in trials and experimentally, but have not yet gained universal acceptance. This review focuses on the definitions, pathogenesis and treatment of HE. Consideration will be given to existing treatment, including avoidance of precipitating factors and novel therapies such as prebiotics, probiotics, antibiotics, laxatives, branched-chain amino acids, shunt embolization and the importance of considering liver transplant in appropriate cases.

Schlagwörter

Stichwörter der Autor:innen

covert hepatic encephalopathyhepatic encephalopathylactulosepathogenesisprobioticsrifaximintreatment

Autor:innen und Institutionen

  • Department of Gastroenterology, Royal Liverpool University Hospital.
  • Faculty of Health and Life Sciences, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.

Zitieren

APA

Swaminathan, M., Ellul, M. A., & Cross, T. J. (2018). Hepatic encephalopathy: current challenges and future prospects. Hepatic Medicine: Evidence and Research. https://doi.org/10.2147/hmer.s118964

Vancouver

Swaminathan M, Ellul MA, Cross TJ. Hepatic encephalopathy: current challenges and future prospects. Hepatic Medicine: Evidence and Research. 2018. doi:10.2147/hmer.s118964

BibTeX
@article{Swaminathan2018,
  author = {Swaminathan, Mirashini and Ellul, Mark Alexander and Cross, Timothy Js},
  title = {Hepatic encephalopathy: current challenges and future prospects},
  journal = {Hepatic Medicine: Evidence and Research},
  year = {2018},
  doi = {10.2147/hmer.s118964}
}
Kostenlos starten →